Preclinical Electron Paramagnetic Resonance Tumor Imager
临床前电子顺磁共振肿瘤成像仪
基本信息
- 批准号:10647895
- 负责人:
- 金额:$ 51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-08 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAcute Respiratory Distress SyndromeAnimalsBiologyBiomedical ResearchBiotechnologyBiteBleomycinBlood VesselsBrain InjuriesBudgetsChemotherapy and/or radiationChicagoCodeComputer softwareDataDevelopmentDiseaseDisease ProgressionDrug IndustryElectron Spin Resonance SpectroscopyEngineeringEquilibriumEvaluationFeedbackFloorFree RadicalsFunctional disorderGenerationsGlutathioneGoalsGrantImageImage EnhancementIndividualIndustrializationIndustryInflammationInflammatoryKineticsKnowledgeLaboratoriesLinkLung diseasesMagnetic Resonance ImagingMalignant NeoplasmsMeasurementMeasuresMediatingMedicalMedical centerMethodsMitochondriaModalityModelingMolecularMonitorMusMyocardial InfarctionMyopathyNerve DegenerationNoiseOxidation-ReductionOxidative StressOxygenOxygen saturation measurementPathologyPenetrationPerformancePeripheralPersonsPhysiologic pulsePhysiologicalPower SourcesProcessPropertyPulse OximetryRadiation therapyReactionReactive Oxygen SpeciesRelaxationReproducibilityResolutionRespiratory TherapyRoleScanningSeveritiesSignal TransductionSourceSpecific qualifier valueSpectrum AnalysisSpeedSpin TrappingStrokeStudentsSuperoxidesSurfaceSystemTechniquesTechnologyTestingTimeTissuesTrainingTraumaTreatment EfficacyTumor PathologyUniversitiesViscosityWorkWritingcancer therapycarcinogenesiscommercializationdata acquisitiondesigndesign and constructionexperienceexperimental studyfrontierhigh riskimage reconstructionimagerimaging modalityimprovedin vivoin vivo imagingin vivo monitoringinnovationlung injurymagnetic fieldmanufacturabilitymembermicrowave electromagnetic radiationnitroxylpre-clinicalpreclinical imagingprototypereconstructionsoftware systemssuccesstargeted cancer therapytreatment responsetumortumor microenvironmentwound healing
项目摘要
Summary
Revolutionary methods of acquiring electron paramagnetic resonance (EPR) spectra of free radicals
create a paradigm shift in application of EPR to understanding the role of radicals in cancer and in other
diseases. Hitherto impossible studies are now feasible.
Molecular oxygen, pH, local viscosity, distribution of probes, and general redox status of tissues are
crucial parameters to understand tumors, determine targets for radiation and chemotherapy, and to monitor
response to treatments. Lung damage, stroke, myocardial infarction, brain injury, wound healing, and other
trauma, and peripheral vascular limitations may similarly benefit from EPR imaging of redox status. These
physiologic parameters can be measured using nitroxide radicals, which are optimally detected with rapid scan
EPR. Pulsed EPR measurement of local oxygen concentration with trityl radicals can guide radiation treatment
of tumors in mice. The proposed system will include both of these powerful techniques. Experienced
collaborators will test the imager in applications to redox equilibria in mouse tumors, reactive oxygen species
related to cancer in mice, and acute lung injury.
Space is at a premium in medical facilities, and in industry floor space for a new modality is expensive.
Looking toward expanded use in the pharmaceutical industry the 1 GHz imager will be compact and
transportable. Smaller, faster, more versatile imaging will enhance applications of oximetric imaging to tumor
therapy and to the other pathologies listed above. The prototype with technology for both rapid scan
spectroscopy and oximetric imaging will open new vistas for quantifying more physiologic parameters than
oximetry alone. The integrated software system will enable use by technicians without advanced training in the
underlying spectroscopy.
The industrial partner, Bruker BioSpin, and University of Denver’s engineers will design a new
generation of 1 GHz cross-loop and surface coil resonators, a small magnet and scan coils. Bruker contributes
supplemental (optional) support beyond the grant budget with engineering team commitments to work on
commercializing our rapid scan EPR method and components. Bruker brings to the team essential experience
and know-how of commercial standards, manufacturability, long-term support, and customer needs. Lack of
the proposed capability has stymied the expansion of EPR capabilities into more general biomedical research
use. The innovation is the creation of a prototype that our team’s industrial component can refine into a
marketable product with powerful EPR capability for end users.
概括
获取自由基电子顺磁共振 (EPR) 谱的革命性方法
应用 EPR 来理解自由基在癌症和其他疾病中的作用,创造了范式转变
疾病。迄今为止不可能的研究现在变得可行。
分子氧、pH、局部粘度、探针分布以及组织的一般氧化还原状态
了解肿瘤、确定放疗和化疗目标以及监测的关键参数
对治疗的反应。肺损伤、中风、心肌梗塞、脑损伤、伤口愈合等
创伤和外周血管限制同样可以受益于氧化还原状态的 EPR 成像。这些
可以使用氮氧自由基来测量生理参数,通过快速扫描可以最佳地检测到氮氧自由基
EPR。用三苯甲基自由基脉冲 EPR 测量局部氧浓度可以指导放射治疗
小鼠肿瘤。拟议的系统将包括这两种强大的技术。经验丰富
合作者将测试成像仪在小鼠肿瘤氧化还原平衡、活性氧中的应用
与小鼠癌症和急性肺损伤有关。
医疗设施中的空间非常宝贵,而在工业中,新模式的占地面积也很昂贵。
为了扩大在制药行业的使用,1 GHz 成像仪将变得紧凑且
可运输。更小、更快、更通用的成像将增强血氧成像在肿瘤中的应用
治疗和上面列出的其他病症。具有快速扫描技术的原型
光谱学和血氧成像将为量化更多的生理参数开辟新的前景
单独进行血氧测定。集成的软件系统将使技术人员无需接受高级培训即可使用
基础光谱学。
工业合作伙伴布鲁克 BioSpin 和丹佛大学的工程师将设计一种新的
生成 1 GHz 交叉环路和表面线圈谐振器、小磁铁和扫描线圈。布鲁克贡献
超出赠款预算的补充(可选)支持,并承诺工程团队致力于开展工作
将我们的快速扫描 EPR 方法和组件商业化。布鲁克为团队带来了重要的经验
以及商业标准、可制造性、长期支持和客户需求方面的专业知识。缺乏
拟议的功能阻碍了 EPR 功能扩展到更一般的生物医学研究
使用。创新是创建一个原型,我们团队的工业组件可以将其细化为
为最终用户提供强大的 EPR 功能的适销产品。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advances in rapid scan EPR spectroscopy.
- DOI:10.1016/bs.mie.2022.02.013
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Spin-spin interaction and relaxation in two trityl-nitroxide diradicals.
- DOI:10.1016/j.jmr.2021.107078
- 发表时间:2021-11
- 期刊:
- 影响因子:0
- 作者:Moore W;Yao R;Liu Y;Eaton SS;Eaton GR
- 通讯作者:Eaton GR
Electron paramagnetic resonance of lanthanides.
- DOI:10.1016/bs.mie.2021.01.038
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gareth R Eaton其他文献
Toward a Nanoencapsulated EPR Imaging Agent for Clinical Use
面向临床使用的纳米封装 EPR 成像剂
- DOI:
10.1007/s11307-023-01863-0 - 发表时间:
2023 - 期刊:
- 影响因子:3.1
- 作者:
Rhia M Martin;Samantha Diaz;Martin Poncelet;B. Driesschaert;Eugene Barth;M. Kotecha;B. Epel;Gareth R Eaton;J. R. Biller - 通讯作者:
J. R. Biller
Gareth R Eaton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gareth R Eaton', 18)}}的其他基金
Preclinical Electron Paramagnetic Resonance Tumor Imager
临床前电子顺磁共振肿瘤成像仪
- 批准号:
10447727 - 财政年份:2021
- 资助金额:
$ 51万 - 项目类别:
Preclinical Electron Paramagnetic Resonance Tumor Imager
临床前电子顺磁共振肿瘤成像仪
- 批准号:
10276077 - 财政年份:2021
- 资助金额:
$ 51万 - 项目类别:
Preclinical Electron Paramagnetic Resonance Tumor Imager
临床前电子顺磁共振肿瘤成像仪
- 批准号:
8877459 - 财政年份:2014
- 资助金额:
$ 51万 - 项目类别:
Preclinical Electron Paramagnetic Resonance Tumor Imager
临床前电子顺磁共振肿瘤成像仪
- 批准号:
9131526 - 财政年份:2014
- 资助金额:
$ 51万 - 项目类别:
In Vivo EPR Bioengineering Research Partnership
体内 EPR 生物工程研究合作伙伴
- 批准号:
6740823 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
Rapid Scan Biomedical EPR Spectroscopy and Imaging
快速扫描生物医学 EPR 光谱和成像
- 批准号:
7434674 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
Rapid Scan Biomedical EPR Spectroscopy and Imaging
快速扫描生物医学 EPR 光谱和成像
- 批准号:
8084124 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
Rapid Scan Biomedical EPR Spectroscopy and Imaging
快速扫描生物医学 EPR 光谱和成像
- 批准号:
7870319 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
In Vivo EPR Bioengineering Research Partnership
体内 EPR 生物工程研究合作伙伴
- 批准号:
6344154 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
In Vivo EPR Bioengineering Research Partnership
体内 EPR 生物工程研究合作伙伴
- 批准号:
6620064 - 财政年份:2002
- 资助金额:
$ 51万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 51万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 51万 - 项目类别:














{{item.name}}会员




